Variants in COL4A1 and COL4A2 have been reported in patients diagnosed with CP41–44, however genetic testing was generally only performed upon evidence of recurrent stroke or evolution of multi-systemic clinical phenotypes. This evidence concerns the gene COL4A2 and stroke disorder.